STOCK TITAN

[Form 4] KORU Medical Systems, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

SEC Form 4 filing: Director Jessica M. Bibliowicz reported the grant of 1,446 restricted stock units (RSUs) of Apollo Global Management, Inc. (APO) on 01 July 2025 under the company’s 2019 Omnibus Equity Incentive Plan. Each RSU converts into one share of common stock when vested and, per Bibliowicz’s deferral election, shares will be issued after she leaves the Board.

Following the grant, the director’s total beneficial ownership rises to 14,472 shares, including 6,802 previously issued RSUs. The transaction carried a stated price of $0 because it is an equity award, not an open-market purchase.

  • The RSUs vest in installments, subject to continued service.
  • No derivative securities were bought or sold, and no cash changed hands.
  • The filing does not disclose any sales, dispositions, or purchases by the insider beyond the single RSU grant.

The activity is routine board compensation and does not materially alter the company’s share count or governance profile, but it affirms alignment of director incentives with shareholder value.

Deposito modulo SEC 4: La direttrice Jessica M. Bibliowicz ha segnalato la concessione di 1.446 unità azionarie vincolate (RSU) di Apollo Global Management, Inc. (APO) il 01 luglio 2025, nell'ambito del Piano Omnibus di Incentivi Azionari 2019 della società. Ogni RSU si trasforma in un'azione ordinaria al momento della maturazione e, secondo la scelta di rinvio di Bibliowicz, le azioni saranno emesse dopo che lascerà il Consiglio.

Dopo la concessione, la posizione complessiva della direttrice sale a 14.472 azioni, inclusi 6.802 RSU precedentemente emessi. L'operazione ha un prezzo dichiarato pari a $0 in quanto si tratta di un premio azionario e non di un acquisto sul mercato aperto.

  • Le RSU maturano in rate, subordinatamente al mantenimento del servizio.
  • Non sono stati acquistati o venduti titoli derivati, né sono stati scambiati contanti.
  • Il deposito non rivela vendite, cessioni o acquisti da parte dell'insider oltre alla singola concessione di RSU.

L'attività rappresenta una normale compensazione del consiglio e non modifica in modo sostanziale il numero di azioni o il profilo di governance della società, ma conferma l'allineamento degli incentivi dei direttori con il valore per gli azionisti.

Presentación del formulario SEC 4: La directora Jessica M. Bibliowicz informó sobre la concesión de 1.446 unidades de acciones restringidas (RSU) de Apollo Global Management, Inc. (APO) el 01 de julio de 2025 bajo el Plan de Incentivos de Capital Omnibus 2019 de la compañía. Cada RSU se convierte en una acción común al momento del otorgamiento y, según la elección de aplazamiento de Bibliowicz, las acciones se emitirán después de que deje la Junta.

Tras la concesión, la posesión total beneficiaria de la directora aumenta a 14.472 acciones, incluyendo 6.802 RSU emitidas previamente. La transacción tiene un precio declarado de $0 porque es una asignación de acciones y no una compra en el mercado abierto.

  • Las RSU se consolidan en cuotas, sujetas a la continuidad del servicio.
  • No se compraron ni vendieron valores derivados, y no hubo intercambio de efectivo.
  • La presentación no revela ventas, disposiciones o compras adicionales por parte del insider más allá de la única concesión de RSU.

La actividad es una compensación rutinaria de la junta y no altera materialmente el número de acciones ni el perfil de gobernanza de la compañía, pero confirma la alineación de los incentivos del director con el valor para los accionistas.

SEC 양식 4 제출: 이사 제시카 M. 비블리오위츠가 2025년 7월 1일 아폴로 글로벌 매니지먼트, Inc.(APO)의 2019년 통합 주식 인센티브 계획에 따라 1,446개의 제한 주식 단위(RSU) 부여를 보고했습니다. 각 RSU는 권리 취득 시 보통주 1주로 전환되며, 비블리오위츠의 연기 선택에 따라 이사회 퇴임 후 주식이 발행됩니다.

부여 후, 이사의 총 실질 소유 주식 수는 14,472주로 증가했으며, 이 중 6,802주는 이전에 발행된 RSU입니다. 이 거래는 주식 보상으로 가격이 $0로 명시되어 있으며, 공개 시장에서의 구매가 아닙니다.

  • RSU는 계속 근무 조건 하에 분할로 권리 취득됩니다.
  • 파생 증권의 매매는 없었으며, 현금 거래도 발생하지 않았습니다.
  • 해당 제출 서류에는 이외의 매도, 처분 또는 매수 내역이 공개되지 않았습니다.

이 활동은 일상적인 이사회 보상이며 회사의 주식 수나 지배 구조에 중대한 변화를 주지 않습니다. 다만 이사 인센티브가 주주 가치와 일치함을 확인시켜줍니다.

Dépôt du formulaire SEC 4 : La directrice Jessica M. Bibliowicz a déclaré l’octroi de 1 446 unités d’actions restreintes (RSU) d’Apollo Global Management, Inc. (APO) le 1er juillet 2025 dans le cadre du Plan d’Incitation Globale 2019 de la société. Chaque RSU se convertit en une action ordinaire à l’acquisition des droits et, selon l’élection de report de Bibliowicz, les actions seront émises après son départ du conseil d’administration.

À la suite de cette attribution, la détention totale bénéficiaire de la directrice s’élève à 14 472 actions, incluant 6 802 RSU précédemment attribuées. La transaction est déclarée à un prix de 0 $ car il s’agit d’une attribution d’actions et non d’un achat sur le marché libre.

  • Les RSU sont acquises par tranches, sous réserve de la poursuite du service.
  • Aucun titre dérivé n’a été acheté ou vendu, et aucune somme d’argent n’a été échangée.
  • Le dépôt ne révèle aucune vente, cession ou achat par l’initié au-delà de cette seule attribution de RSU.

Cette opération relève d’une rémunération courante du conseil et n’altère pas de manière significative le nombre d’actions ni le profil de gouvernance de la société, mais elle confirme l’alignement des incitations des administrateurs avec la valeur pour les actionnaires.

SEC Formular 4 Einreichung: Direktorin Jessica M. Bibliowicz meldete die Gewährung von 1.446 Restricted Stock Units (RSUs) von Apollo Global Management, Inc. (APO) am 01. Juli 2025 im Rahmen des Omnibus Equity Incentive Plans 2019 des Unternehmens. Jede RSU wandelt sich bei Vesting in eine Stammaktie um, und gemäß Bibliowicz' Aufschubwahl werden die Aktien erst nach ihrem Ausscheiden aus dem Vorstand ausgegeben.

Nach der Gewährung steigt das gesamte wirtschaftliche Eigentum der Direktorin auf 14.472 Aktien, einschließlich 6.802 zuvor ausgegebener RSUs. Die Transaktion hat einen angegebenen Preis von 0 $, da es sich um eine Aktienzuteilung handelt und keinen Kauf am offenen Markt.

  • Die RSUs werden in Raten vestet, vorbehaltlich fortgesetzter Dienstzeit.
  • Es wurden keine Derivate gekauft oder verkauft, und es fand kein Bargeldtransfer statt.
  • Die Einreichung offenbart keine Verkäufe, Veräußerungen oder Käufe durch den Insider über die einzelne RSU-Gewährung hinaus.

Die Transaktion ist eine routinemäßige Vorstandsvergütung und ändert weder die Aktienanzahl noch das Governance-Profil des Unternehmens wesentlich, bestätigt jedoch die Ausrichtung der Anreize der Direktoren am Aktionärswert.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine director RSU grant; negligible share impact; neutral for investors.

The 1,446-unit award represents roughly 0.0008% of APO’s ~180 million shares outstanding—immaterial from an ownership-concentration perspective. Such grants are standard practice for large-cap asset managers and help maintain director–shareholder alignment without cash outlay. No red flags: no accelerated vesting, no unusual pricing, and deferral until board departure mirrors best-practice governance. I classify the market impact as neutral.

Deposito modulo SEC 4: La direttrice Jessica M. Bibliowicz ha segnalato la concessione di 1.446 unità azionarie vincolate (RSU) di Apollo Global Management, Inc. (APO) il 01 luglio 2025, nell'ambito del Piano Omnibus di Incentivi Azionari 2019 della società. Ogni RSU si trasforma in un'azione ordinaria al momento della maturazione e, secondo la scelta di rinvio di Bibliowicz, le azioni saranno emesse dopo che lascerà il Consiglio.

Dopo la concessione, la posizione complessiva della direttrice sale a 14.472 azioni, inclusi 6.802 RSU precedentemente emessi. L'operazione ha un prezzo dichiarato pari a $0 in quanto si tratta di un premio azionario e non di un acquisto sul mercato aperto.

  • Le RSU maturano in rate, subordinatamente al mantenimento del servizio.
  • Non sono stati acquistati o venduti titoli derivati, né sono stati scambiati contanti.
  • Il deposito non rivela vendite, cessioni o acquisti da parte dell'insider oltre alla singola concessione di RSU.

L'attività rappresenta una normale compensazione del consiglio e non modifica in modo sostanziale il numero di azioni o il profilo di governance della società, ma conferma l'allineamento degli incentivi dei direttori con il valore per gli azionisti.

Presentación del formulario SEC 4: La directora Jessica M. Bibliowicz informó sobre la concesión de 1.446 unidades de acciones restringidas (RSU) de Apollo Global Management, Inc. (APO) el 01 de julio de 2025 bajo el Plan de Incentivos de Capital Omnibus 2019 de la compañía. Cada RSU se convierte en una acción común al momento del otorgamiento y, según la elección de aplazamiento de Bibliowicz, las acciones se emitirán después de que deje la Junta.

Tras la concesión, la posesión total beneficiaria de la directora aumenta a 14.472 acciones, incluyendo 6.802 RSU emitidas previamente. La transacción tiene un precio declarado de $0 porque es una asignación de acciones y no una compra en el mercado abierto.

  • Las RSU se consolidan en cuotas, sujetas a la continuidad del servicio.
  • No se compraron ni vendieron valores derivados, y no hubo intercambio de efectivo.
  • La presentación no revela ventas, disposiciones o compras adicionales por parte del insider más allá de la única concesión de RSU.

La actividad es una compensación rutinaria de la junta y no altera materialmente el número de acciones ni el perfil de gobernanza de la compañía, pero confirma la alineación de los incentivos del director con el valor para los accionistas.

SEC 양식 4 제출: 이사 제시카 M. 비블리오위츠가 2025년 7월 1일 아폴로 글로벌 매니지먼트, Inc.(APO)의 2019년 통합 주식 인센티브 계획에 따라 1,446개의 제한 주식 단위(RSU) 부여를 보고했습니다. 각 RSU는 권리 취득 시 보통주 1주로 전환되며, 비블리오위츠의 연기 선택에 따라 이사회 퇴임 후 주식이 발행됩니다.

부여 후, 이사의 총 실질 소유 주식 수는 14,472주로 증가했으며, 이 중 6,802주는 이전에 발행된 RSU입니다. 이 거래는 주식 보상으로 가격이 $0로 명시되어 있으며, 공개 시장에서의 구매가 아닙니다.

  • RSU는 계속 근무 조건 하에 분할로 권리 취득됩니다.
  • 파생 증권의 매매는 없었으며, 현금 거래도 발생하지 않았습니다.
  • 해당 제출 서류에는 이외의 매도, 처분 또는 매수 내역이 공개되지 않았습니다.

이 활동은 일상적인 이사회 보상이며 회사의 주식 수나 지배 구조에 중대한 변화를 주지 않습니다. 다만 이사 인센티브가 주주 가치와 일치함을 확인시켜줍니다.

Dépôt du formulaire SEC 4 : La directrice Jessica M. Bibliowicz a déclaré l’octroi de 1 446 unités d’actions restreintes (RSU) d’Apollo Global Management, Inc. (APO) le 1er juillet 2025 dans le cadre du Plan d’Incitation Globale 2019 de la société. Chaque RSU se convertit en une action ordinaire à l’acquisition des droits et, selon l’élection de report de Bibliowicz, les actions seront émises après son départ du conseil d’administration.

À la suite de cette attribution, la détention totale bénéficiaire de la directrice s’élève à 14 472 actions, incluant 6 802 RSU précédemment attribuées. La transaction est déclarée à un prix de 0 $ car il s’agit d’une attribution d’actions et non d’un achat sur le marché libre.

  • Les RSU sont acquises par tranches, sous réserve de la poursuite du service.
  • Aucun titre dérivé n’a été acheté ou vendu, et aucune somme d’argent n’a été échangée.
  • Le dépôt ne révèle aucune vente, cession ou achat par l’initié au-delà de cette seule attribution de RSU.

Cette opération relève d’une rémunération courante du conseil et n’altère pas de manière significative le nombre d’actions ni le profil de gouvernance de la société, mais elle confirme l’alignement des incitations des administrateurs avec la valeur pour les actionnaires.

SEC Formular 4 Einreichung: Direktorin Jessica M. Bibliowicz meldete die Gewährung von 1.446 Restricted Stock Units (RSUs) von Apollo Global Management, Inc. (APO) am 01. Juli 2025 im Rahmen des Omnibus Equity Incentive Plans 2019 des Unternehmens. Jede RSU wandelt sich bei Vesting in eine Stammaktie um, und gemäß Bibliowicz' Aufschubwahl werden die Aktien erst nach ihrem Ausscheiden aus dem Vorstand ausgegeben.

Nach der Gewährung steigt das gesamte wirtschaftliche Eigentum der Direktorin auf 14.472 Aktien, einschließlich 6.802 zuvor ausgegebener RSUs. Die Transaktion hat einen angegebenen Preis von 0 $, da es sich um eine Aktienzuteilung handelt und keinen Kauf am offenen Markt.

  • Die RSUs werden in Raten vestet, vorbehaltlich fortgesetzter Dienstzeit.
  • Es wurden keine Derivate gekauft oder verkauft, und es fand kein Bargeldtransfer statt.
  • Die Einreichung offenbart keine Verkäufe, Veräußerungen oder Käufe durch den Insider über die einzelne RSU-Gewährung hinaus.

Die Transaktion ist eine routinemäßige Vorstandsvergütung und ändert weder die Aktienanzahl noch das Governance-Profil des Unternehmens wesentlich, bestätigt jedoch die Ausrichtung der Anreize der Direktoren am Aktionärswert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WHOLIHAN EDWARD

(Last) (First) (Middle)
C/O KORU MEDICAL SYSTEMS, INC.
100 CORPORATE DRIVE

(Street)
MAHWAH NJ 07430

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A 4,189 A $3.58 37,772 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.
/s/ Thomas Adams- Attorney-in-Fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many APO shares did Director Jessica Bibliowicz acquire on 1-Jul-2025?

She received 1,446 restricted stock units, each convertible into one common share upon vesting.

What is Jessica Bibliowicz’s total beneficial ownership in APO after the grant?

Her ownership increased to 14,472 shares, including 6,802 RSUs.

Did the insider pay cash for the APO shares?

No. The award was a zero-price RSU grant under the 2019 Omnibus Plan.

When will the RSUs granted to Bibliowicz vest?

They vest in installments per the RSU agreement, provided she remains on the Board through each vesting date.

Will the newly granted APO shares be issued immediately?

No. Under her deferral election, shares will be issued only after she ends her board service.
Koru Med Sys

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Latest SEC Filings

KRMD Stock Data

165.18M
42.63M
7.12%
50.93%
1.11%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MAHWAH